本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cidara Therapeutics, Inc.

221.38
0.0000
成交量:- -
成交額:- -
市值:69.60億
市盈率:-19.73
高:221.38
開:221.38
低:221.38
收:221.38
52周最高:221.42
52周最低:63.50
股本:3,143.94萬
流通股本:3,109.34萬
量比:2.02
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-11.2200
每股收益(LYR):-26.7460
淨資產收益率:-68.70%
總資產收益率:-29.35%
市淨率:16.48
市盈率(LYR):-8.28

資料載入中...

2024/12/05

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/12/04

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/26

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/26

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

重要事件披露

Form 8-K - Current report
2024/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/09/23

重要事件披露

Form 8-K - Current report
2024/09/12

重要事件披露

Form 8-K - Current report
2024/08/13

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/07/30

SEC問詢函

Form CORRESP - Correspondence
2024/07/29

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/07/29

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/07/26

超過5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/07/19

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/07/18

重要事件披露

Form 8-K - Current report
2024/05/20

重要事件披露

Form 8-K - Current report
2024/05/16

重要事件披露

Form 8-K - Current report